
Brandon Colby, MD
MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
About Brandon
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Education
- BA in Genetics with Honors, University of Michigan · 2000
- MD, Mount Sinai School of Medicine · 2004
- MBA, Stanford University Graduate School of Business · 2007
Affiliations & Memberships
- Affiliate Specialist, American College of Medical Genetics and Genomics (ACMG)
- Associate, American College of Preventive Medicine (ACPM)
- Member, National Society of Genetic Counselors (NSGC)
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.
Articles by Brandon
Settings
2-Step Verification
Enabling 2-Step Verification

Ambiguity in Diagnosis: Unraveling Acute Leukemia of Ambiguous Lineage with Genetic Testing
Explore how genetic testing aids in diagnosing Acute Leukemia of Ambiguous Lineage by identifying mutations, guiding treatment plans, and improving patient outcomes.

Analyzing Acute Liver Failure: The Genetic Testing Frontier
Explore how genetic testing is revolutionizing pediatric acute liver failure diagnosis and treatment, highlighting whole-exome sequencing's role and future implications.

Advancing Understanding: Genetic Testing in Acute Megakaryoblastic Leukemia
Genetic testing enhances precision in diagnosing acute megakaryoblastic leukemia, aids personalized treatment, and develops targeted therapies, revolutionizing patient care.

Acute Myeloid Leukemia: Unraveling the Genetic Threads of a Complex Disease
Explore the impact of genetic testing on Acute Myeloid Leukemia. Understand GFI1-36N SNP's role in diagnosis, personalized treatment, and monitoring in AML.